Source:http://linkedlifedata.com/resource/pubmed/id/17448770
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
4
|
| pubmed:dateCreated |
2007-4-23
|
| pubmed:abstractText |
Necrotizing enterocolitis (NEC), the devastating enteric process of premature neonates, is marked by severe intravascular abnormalities and disseminated intravascular coagulation. Treatment to date remains historical and continues to be merely supportive without attempts to ameliorate progress within the inflammatory or coagulation cascades. Antithrombin III (ATIII) supplementation has been shown to favorably alter the process of disseminated intravascular coagulation and sepsis in adults. However, no reported use of this treatment exists in neonates. Therefore, we analyze the efficacy of our recent experience with ATIII replacement therapy in neonates with NEC.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Apr
|
| pubmed:issn |
1531-5037
|
| pubmed:author | |
| pubmed:issnType |
Electronic
|
| pubmed:volume |
42
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
704-8
|
| pubmed:meshHeading |
pubmed-meshheading:17448770-Anticoagulants,
pubmed-meshheading:17448770-Antithrombin III,
pubmed-meshheading:17448770-Blood Transfusion,
pubmed-meshheading:17448770-Disseminated Intravascular Coagulation,
pubmed-meshheading:17448770-Enterocolitis, Necrotizing,
pubmed-meshheading:17448770-Female,
pubmed-meshheading:17448770-Humans,
pubmed-meshheading:17448770-Infant, Newborn,
pubmed-meshheading:17448770-Male
|
| pubmed:year |
2007
|
| pubmed:articleTitle |
The initial experience of antithrombin III in the management of neonates with necrotizing enterocolitis.
|
| pubmed:affiliation |
Department of Pediatric Surgery, Children's Mercy Hospital, Kansas City, MO 64108, USA.
|
| pubmed:publicationType |
Journal Article
|